-
Current Recommendation: Celldex Therapeutics (Nasdaq: CLDX) December 28, 2009
Posted in Access Report.
No comments -
Current Recommendation: Delcath Systems Inc. (Nasdaq: DCTH) December 28, 2009
Posted in Access Report.
No comments -
Chalk Up Gains Of 17% On Silver Wheaton And 21% On Conseco… And A New Gold play December 22, 2009
Posted in Strategic Income.
No comments
